Biobanking Market Size to Reach USD 67.90 Billion in 2030 | Increase in Research Activities for Regenerative Medicines, Stem Cell Therapeutics and Cell and Gene Therapy are Key Factors Driving Industry Demand, According to Emergen Research – PRNewswire

Searching for your content…
In-Language News
Contact Us
from 8 AM – 10 PM ET
News provided by
Feb 07, 2022, 08:00 ET
Share this article
VANCOUVER, BC, Feb. 7, 2022 /PRNewswire/ — The global biobanking market size was USD 29.79 Billion in 2020. Increasing need for genetic testing and personalized medicine are key factors driving global market revenue growth. Biobanks play a crucial role in biomedical research. Biobanks not only speed up the process of transfer of scientific knowledge into technical applications, but also give rise to situations, where obtaining such knowledge is dependent mainly on technology.
Drivers: Increased application in clinical and scientific research
Biobanks are an important resource for genomics, proteomics, metabolomic research, molecular epidemiology, translational studies, and therapeutic target creation. Thus, academic and industry researchers are showing increased interest in biobanking. Biobanking is gaining traction in the field of biomedical research. Several biobanks across the globe are assisting in medical research and clinical trials of personalized medicine as they aid in identification of biomarkers and various pharmaceutical treatments.
Get Free Sample PDF Copy of the [email protected]
Restraints: Issues related to procurement of samples
A key factor limiting growth of the global biobanking market is issues related with procurement of biospecimen samples which is a complex procedure and involves complications and processes to be fulfilled. Moreover, biobanking equipment are expensive and this limits adoption in some developing countries.
Growth Projections
The global biobanking market size is expected to reach USD 67.90 Billion in 2030 and register a revenue CAGR of 8.6% over the forecast period. Increased focus on regenerative medicine for treatment of cancer, diabetes, Alzheimer’s Disease, and other rare genetic diseases is driving biobanking market revenue growth. Umbilical cords and stem cells are preserved in biobanks to help in development of regenerative medicines and the trend is gaining traction currently.
COVID-19 Direct Impacts
Biobanking market registered significant growth during the COVID-19 pandemic as researchers stored numerous samples of bronchioalveolar lavage, oropharyngeal/ nasopharyngeal swabs, blood, sputum, urine, and stool of infected patients. The samples were collected and archived for future use to develop diagnostics, therapies, and vaccines. COVID-19 biorepositories in India alone collected over 40,000 samples for researchers to develop vaccines/therapies.
Current Trends and Innovations
Biobanks has entered the Big Data era with advancements in Artificial Intelligence (AI)-driven data analytics, process automation, robotics, and other technological advancements. This has resulted in higher quality biobanking data and contribute to a shift to data driven science. Well processed Big Data allow collaboration of biobanks in different regions and with advanced technology, these data can be handled easily. Storage option on cloud also helps resolve limited local storage capacity issue.
Geographical Outlook
Market in North America accounted for largest revenue share in 2020 due to advancements in drug discovery and increased investment in personalized and regenerative medicine. Increasing prevalence of cancer, cardiovascular, and infectious diseases is boosting growth of the market in the region. Large number of clinical trials related to COVID-19 and increasing usage of stem cell therapies for treatment of various chronic diseases is also driving market growth.
Looking for Discount on Biobanking market report [Click Here]@
Strategic Initiatives
In July 2021, BioIVT, which is a U.S.-based provider of research and high-quality biological specimens and value-added services, acquired Tissue Solutions Ltd., which is a virtual biobank in the U.K. The acquisition will add 150 collection sites to BioIVT’s network, giving access to high-quality control and disease state biospecimen. It will also help in expanding skin product offerings for in-vitro models.
Some Key Highlights From the Report
Explore Complete Report Description and Table of Contents of Biobanking Market [email protected]
Emergen Research has segmented the global biobanking market on the basis of product & services, sample type, storage type, application, and region:
Buy Your Exclusive [email protected]
Want to Explore Complete Table of Content (TOC) for Biobanking Market[Click Here]@
Latest Published Reports by Emergen Research in Healthcare And Pharmaceuticals Industry Segment:
Targeted Therapeutics Market, By Therapy (Monoclonal Antibodies, Small Molecule Inhibitors), By Disease Indication, By End-use, and By Region Forecast to 2028.
Dermal Regeneration Template Market By Type (Fortified Type, Fenestrated Type, Single Layer Type), By Application (Massively Burned Patients, Acutely Excised Wounds, Chronic Wounds, Others), By End Use (Hospital, Wound Care, Others) By Region Forecast to 2028.
Telehealth Market, By Type (Tele-Home and Tele-Hospital), By Component, By Deployment Model (Web & Cloud-based and On-premises), By Application, By End-user, and By Region Forecast to 2028.
Augmented Reality and Virtual Reality in Healthcare Market By Technology (Augmented Reality, Virtual Reality), By Component (Hardware, Software, Services), By Application (Surgery, Training & Education), By End-use (Hospitals, Clinics), and By Region Forecast to 2030.
Leadless Pacemaker Systems Market, By Product Type, By Application (Atrial Fibrillation, Sinus Node Dysfunction, Atrioventricular Block and Others), By Technology, By End-use, and By Region Forecast to 2028.
Biodefense Market Size, Share, Trends, By Product Type (COVID-19 Vaccine, Anthrax Vaccine, Others), By Biothreat Detection Device Type, By End-Use, and By Region Forecast to 2028.
Cryotherapy Market By Product (Localized Cryotherapy Devices, Cryosurgery Devices, Cryochambers & Cryosaunas, Gas Cylinders, Others), By Therapy (Icepack Therapy, Cryosurgery, Chamber Therapy), By Application, By End-Use, and By Region Forecast to 2028
About Emergen Research 
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web:  
Direct Line: +1 (604) 757-9756
E-mail: [email protected]  
Visit for More Insights:  
Explore Our Custom Intelligence services | Growth Consulting Services 
Read our Press Release on Biobanking @
SOURCE Emergen Research
More news releases in similar topics
Cision Distribution 888-776-0942
from 8 AM – 9 PM ET


Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart